Respiratorius AB

The Swedish market will close at 13:00 on 2 April. The Norwegian and Danish markets will be closed on 2 April. On 3 and 6 April, the Swedish, Norwegian and Danish markets will be closed.

Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer, and especially aggressive lymphoma. The company was established in 1999 as a spin-off from Lund University. The operations are located in Sweden, where research is conducted in-house, but also through international partners. The company has its headquarters in Lund.

Quotes for Respiratorius AB

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Johan Drott

Chairperson of the Board

  • Karin Wehlin

Board

  • Johan Drott
  • Mia Lundblad
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    Bolagspresentation och Q&A med Johan Drott

    Johan Drott CEO presenterar på Life Science Day 2019

    Johan Drott CEO, presenterar på Redeye Investor Forum - 10 sep

    Johan Drott, CEO Respiratorius

    Largest Owners

    Name Capital % Votes % Date
    Avanza Pension 8,31 8,31 2025-12-23
    Hans Mandahl 4,05 4,05 2025-12-23
    Valcuria Holding AB 3,70 3,70 2025-12-23
    Hartmut Wiese 2,53 2,53 2025-12-23
    Ulf Stahlin 1,21 1,21 2025-12-23
    Erik Boström 1,21 1,21 2025-12-23
    Håkan Svensson 1,14 1,14 2025-12-23
    Per Vasilis 1,11 1,11 2025-12-23
    Gerhard Dal 1,11 1,11 2025-12-23
    Christian Müller 1,06 1,06 2025-12-23
    ** Powered by Modular Finance

    Insider trading

    *Powered by Modular Finance

    Key Numbers

    *Compiled data from Millistream

    Upcoming reports

    • 2026-05-26 Interim Report 2026-Q1

    • 2026-06-09 Annual General Meeting 2025

    • 2026-08-11 Interim Report 2026-Q2

    • 2026-11-10 Interim Report 2026-Q3

    • 2027-02-09 Year End Report 2026

    Annual reports, prospectus etc.